Such assays would find application in high-throughput screening for novel antiviral agents.
For peroxiredoxins, such assays have led to widespread underestimates of their catalytic power.
Although many such assays are available, few systems are capable of simultaneously detecting all three targets in a single reaction.
The current trend is to assemble many such assays in parallel for enzyme profiling and enzyme fingerprinting.
Assays that use cocktails of RD1 antigens seem to overcome this problem, and such assays have the highest accuracy.
However, such assays can lead to discovery of novel, relevant behaviors.
Secondly any data previously generated from such assays may have an element of bias.
Although such assays can be helpful in vitro, it is unclear whether autophosphorylation is physiologically relevant.
Such assays are designed for exploratory studies.
Such assays may have the potential to predict drug response.
Such assays are now available for use in multicentre trials.
